基于透明质酸支架联合骨髓抽取浓缩液的一步法软骨修复治疗膝关节全层软骨损伤:平均随访14年的长期结局
该前瞻性病例系列研究纳入26例接受透明质酸支架联合骨髓抽取浓缩液(HA-BMAC)一步法修复膝关节全层软骨损伤的患者,平均随访14.0年,22例完成最终随访,末次随访中位VAS评分0.6较术前中位5.0显著降低(P<.001),KOOS各亚量表评分均较术前升高(P≤.001),共3例治疗失败。
要点
- HA-BMAC一步法修复膝关节全层软骨损伤后平均14.0年随访,中位VAS评分0.6较术前5.0显著降低(P<.001)。
- 末次随访中位KOOS疼痛92、症状86、日常生活96、运动85、生活质量88,均较术前升高(P≤.001)。
- 共26例中3例治疗失败,1例在髌骨软骨损伤HA-BMAC治疗后12年行内侧间室单髁关节置换。
核心结论
- HA-BMAC一步法修复膝关节全层软骨缺损在平均随访14.0年时获得成功的长期临床结局并维持关节功能。
- 在活动量正常、非肥胖患者中,跨越广泛年龄范围和损伤类型(包括多间室受累、相关疾病治疗及大或双极软骨损伤)均一致显示长期临床成功。
研究设计与样本
- 研究设计为病例系列,证据等级4级。
- 患者在接受HA-BMAC治疗膝关节全层关节软骨损伤后接受前瞻性随访,平均随访时长14.0年。
- 临床评估采用患者报告的视觉 analog 量表(VAS)和膝关节损伤与骨关节炎结局评分(KOOS),于术前和末次随访时完成。
主要发现
- 共26例患者纳入前瞻性随访,平均年龄48.3岁(17例男性,9例女性),软骨损伤大小中位数6.6 cm²(范围1-27 cm²)。
- 共3例治疗失败,其中1例在髌骨软骨损伤HA-BMAC治疗后12年行内侧间室单髁关节置换。
- 剩余22例患者平均末次随访时长14.0年(范围12-16年),中位VAS评分0.6较术前中位5.0显著降低(P<.001)。
- 末次随访中位KOOS疼痛92、症状86、日常生活96、运动85、生活质量88,均较术前评分升高(P≤.001)。
- 临床结局评分与体重指数无相关性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: One-step cell-based techniques of cartilage repair that lead to restoration of durable chondral tissue and long-term maintenance of joint function are cost-effective and ideal for routine use. PURPOSES: To examine the long-term clinical outcomes, after a mean follow-up duration of 14 years, of cartilage repair in the knee using a hyaluronic acid-based scaffold in association with bone marrow aspirate concentrate (HA-BMAC) and to evaluate the effect of age, lesion characteristics, and associated treatments on the outcome of this cartilage repair method. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: Patients were followed prospectively for a mean duration of 14.0 years after undergoing treatment of knee full-thickness articular cartilage injury using HA-BMAC. Clinical evaluation consisted of the patient-reported scoring tools of the visual analog scale and the Knee injury and Osteoarthritis Outcome Score, which were completed preoperatively and at the time of final follow-up. RESULTS: A total of 26 patients with a mean age of 48.3 years (17 male, 9 female) and median chondral lesion size of 6.6 cm2 (range, 1-27 cm2) were followed prospectively. There were 3 treatment failures, and 1 patient who underwent medial compartment unicompartmental arthroplasty 12 years after HA-BMAC treatment of patellar chondral injury. Of the 22 remaining patients, after a mean final follow-up duration of 14.0 years (range, 12-16 years), the median visual analog scale score of 0.6 was significantly decreased from the preoperative median score of 5.0 (P < .001). The median Knee injury and Osteoarthritis Outcome Score Pain (92), Symptoms (86), Activities of Daily Living (96), Sports (85), and Quality of Life (88) subscale values were all increased compared with the preoperative scores (P≤ .001). There was no correlation of clinical outcome score and body mass index. CONCLUSION: One-step cartilage repair of full-thickness chondral defects in the knee using an HA-BMAC led to successful long-term clinical outcomes and maintenance of joint junction after a mean follow-up duration of 14 years. Long-term clinical success in active, nonobese patients has been uniformly demonstrated across a wide range of patient ages and lesion types, including cases of multicompartment involvement, treatment of associated conditions, and large or bipolar chondral lesions.
引用
- Whyte GP, Bizzoco L, Gobbi A, et al. One-Step Cartilage Repair of Full-Thickness Knee Chondral Lesions Using a Hyaluronic Acid-Based Scaffold Embedded With Bone Marrow Aspirate Concentrate: Long-term Outcomes After Mean Follow-up Duration of 14 Years. Am J Sports Med. 2024. PMID: 39491512. doi:10.1177/03635465241287524
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。